BlackRock’s DiaMedica Therapeutics DMAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.6M Sell
1,856,187
-44,712
-2% -$354K ﹤0.01% 3353
2025
Q4
$15.1M Buy
1,900,899
+222,760
+13% +$1.67M ﹤0.01% 3244
2025
Q3
$11.5M Buy
1,678,139
+486,326
+41% +$2.64M ﹤0.01% 3384
2025
Q2
$4.65M Buy
1,191,813
+1,085,463
+1,021% +$4.23M ﹤0.01% 3801
2025
Q1
$403K Sell
106,350
-1,530
-1% -$8.75K ﹤0.01% 4453
2024
Q4
$586K Buy
107,880
+90
+0.1% +$424 ﹤0.01% 4369
2024
Q3
$452K Buy
107,790
+2,487
+2% +$9.18K ﹤0.01% 4353
2024
Q2
$311K Buy
105,303
+1,933
+2% +$5.3K ﹤0.01% 4452
2024
Q1
$286K Sell
103,370
-1,362
-1% -$3.96K ﹤0.01% 4515
2023
Q4
$297K Buy
104,732
+3,007
+3% +$7.44K ﹤0.01% 4544
2023
Q3
$262K Buy
101,725
+29,810
+41% +$95.7K ﹤0.01% 4602
2023
Q2
$311K Buy
71,915
+245
+0.3% +$595 ﹤0.01% 4621
2023
Q1
$110K Buy
71,670
+1,733
+2% +$2.75K ﹤0.01% 4935
2022
Q4
$111K Buy
69,937
+1,067
+2% +$1.44K ﹤0.01% 5012
2022
Q3
$85K Buy
68,870
+2,153
+3% +$3.37K ﹤0.01% 5221
2022
Q2
$135K Buy
66,717
+10,278
+18% +$24K ﹤0.01% 5146
2022
Q1
$141K Sell
56,439
-2,133
-4% -$6.05K ﹤0.01% 5199
2021
Q4
$219K Buy
58,572
+2,602
+5% +$10.2K ﹤0.01% 5089
2021
Q3
$225K Sell
55,970
-5,289
-9% -$20.2K ﹤0.01% 4954
2021
Q2
$273K Buy
61,259
+1,094
+2% +$8.97K ﹤0.01% 4832
2021
Q1
$551K Buy
60,165
+4,384
+8% +$41K ﹤0.01% 4594
2020
Q4
$566K Buy
55,781
+12,008
+27% +$65.7K ﹤0.01% 4332
2020
Q3
$185K Sell
43,773
-735
-2% -$3.89K ﹤0.01% 4424
2020
Q2
$309K Buy
44,508
+6,135
+16% +$27.4K ﹤0.01% 4292
2020
Q1
$108K Buy
38,373
+6,320
+20% +$26.1K ﹤0.01% 4338
2019
Q4
$156K Buy
32,053
+6,441
+25% +$20K ﹤0.01% 4364
2019
Q3
$53K Sell
25,612
-1,463
-5% -$4.73K ﹤0.01% 4530
2019
Q2
$134K Buy
27,075
+16,651
+160% +$57.6K ﹤0.01% 4427
2019
Q1
$47K Buy
+10,424
New +$37.6K ﹤0.01% 4485

Other funds holding DMAC